Tissue evaluation of immune markers in endometrial and cervical carcinomas

Journal of Experimental and Clinical Cancer Research

Volumn 23, Issue 2, 2004, Pages 269-275

  Lazaris, Andreas Ch ^a   Chatzigianni, E B ^a   Xidias, G ^a   Panoskaltsis, T A ^a   Thomopoulou, G C ^a   Eftychiadis, C A ^a   Michalas, S ^a   Patsouris, E S ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Antigens HLA DR; Endometrial carcinoma; Immunohistochemistry; Stage; T4 lymphocytes; Uterine cervical carcinoma

Indexed keywords

AVIDIN; BIOTIN; CD4 ANTIGEN; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; MONOCLONAL ANTIBODY; TUMOR MARKER;

ADULT; ANTIBODY LABELING; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ENDOTHELIUM CELL; EVALUATION; FEMALE; HISTIOCYTE; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOPEROXIDASE STAINING; INTRACELLULAR SPACE; INVASIVE CARCINOMA; LYMPHOCYTE ACTIVATION; LYMPHOID CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; ANTIGEN-PRESENTING CELLS; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CD4-POSITIVE T-LYMPHOCYTES; CERVIX UTERI; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOCYTE ACTIVATION; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 3242687056     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Accola S.R., Adorini L., Sartoris S., Sinigaglia F., Guardiola J.: MHC: Orchestrating the immune response. Immunol. Today 16: 8-11, 1995.
2. Goedegebuure P.S., Eberlein T.J.: The role of CD4+ tumor-infiltrating lymphocytes in human solid tumors. Immunol. Res. 14: 119-131, 1995.
3. Hohn H., Pilch H., Gunzel S., Neukirch C., Freitag K., Necker A.: Human papillomavirus type 33E7 peptides presented by HLA-DR*0402 to tumor-infiltrating T cells in cervical cancer. J. Virol. 74: 6632-6636, 2000.
4. Nelson J.H., Averette H.E., Richart R.M.: Dysplasia, carcinoma in situ and early cervical cancer. CA Cancer J. Clin. 34: 306-327, 1984.
5. Chadburn A.: Monoclonal antibody OPD4 detects neoplastic T cells but does not distinguish between CD4 and CD8 neoplastic T cells in paraffin tissue sections. Hum. Pathol. 23: 940-947, 1992.
6. Gaffney E.V., Halpin D.P., Moody W.E., Elliott C.B.: Immunocytochemical analysis of hormone receptors with malignant cells separated from human mammary tumors. Am. J. Clin. Pathol. 102(1): 68-71, 1994.
7. Ricaniadis N., Kataki A., Agnantis N., Androulakis G., Karakousis C.P.: Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma. Eur. J. Surg. Oncol. 27: 88-93, 2001.
8. Sikorska B., Wagrowska-Danilewicz M., Danilewicz M.: Prognostic significance of apoptosis in laryngeal cancer. A quantitative immunomorphological study. Acta Histochem. 102: 413-425, 2000.
9. Feinmesser M., Sulkes A., Morgenstern S., Sulkes J., Stern S., Okon E.: HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities. J. Clin. Pathol. 53: 286-291, 2000.
10. Hachisuga T., Fukuda K., Nakamura S., Iwazaka T., Sugimori H.: Local immune response in endometrial carcinomas. Br. J. Obstet. Gynaecol. 104: 110-114, 1997.
11. Coleman N., Stanley M.A.: Analysis of HLADR expression on keratinocytes in cervical neoplasia. Int. J. Cancer 56: 314-319, 1994.
12. Hohn H., Pilsh H., Gunzel S., Neukirch C., Hilmes C., Kaufmann A.: CD4+ tumor-infiltrating lymphocytes in cervical cancer recognize HLA-DR restricted peptides provided by human papillomavirus-E7. J. Immunol. 163: 5715-5722, 1999.
13. de Gruijl T.D., Bontkes H.J., Walboomers J.M., Stukart M.J., Doehjie F.S., Remmink A.J.: Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: A longitudinal study. Cancer Res. 58: 1700-1706, 1998.
14. Odunsi K., Terry G., Ho L., Bell J., Cuzick J., Ganesan T.S.: Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles. Int. J. Cancer 67: 595-602, 1996.
15. Novellino P.S., Trejo Y.G., Beviacqua M., Bordenave R.H., Rumi L.S.: Regulation of HLA-DR antigen in monocytes from colorectal cancer patients by in vitro treatment with human recombinant interferon-gamma. J. Investig. Allergol. Clin. Immunol. 10: 90-93, 2000.
16. Lazaris A.C., Theodoropoulos G.E., Aroni K., Saetta A., Davaris P.S.: Immunohistochemical expression of C-myc oncogene, heat shock protein 70 and HLA-DR molecules in malignant cutaneous melanoma. Virchows Arch. 426: 461-467, 1995.
17. Ishigama S., Natsugoe S., Tokuda K., Nakajo A., Iwashige H., Aridome K.: Invariant chain expression in gastric cancer. Cancer Lett. 10: 87-91, 2001.
18. Brasanac D., Markovic-Lipkovski J., Hadzi-Djokic J., Muller G.A., Muller C.A.: Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data. Neoplasma 46: 173-178, 1999.
19. Ioachim E., Charchanti A., Stavropoulos N.E., Skopelitou A., Athanassiou E.D., Agnantis N.J.: Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma. Histol. Histopathol. 15: 721-727, 2000.